Advanced Systemic Therapies Are Mostly Injectable Biologics
Biologics Have Numerous Limitations, Making Orals Preferred by Most Patients




                             • Inconvenient, burdensome,               >90%
                               and often painful for patients     WOULD SWITCH
                                                                   TO AN ORAL
                             • Immunogenicity risks
                                                                    OPTION1
                             • In-office injection training
                               costs HCPs valuable time and
                               resources

                             • Expensive to manufacture;
                               cold chain delivery/storage



                                                                                 6
